Skip to main content
PLOS One logoLink to PLOS One
. 2023 Nov 29;18(11):e0292644. doi: 10.1371/journal.pone.0292644

Estimating spatially disaggregated probability of severe COVID-19 and the impact of handwashing interventions: The case of Zimbabwe

George Joseph 1, Sveta Milusheva 2, Hugh Sturrock 3, Tonderai Mapako 4, Sophie Ayling 1,*, Yi Rong Hoo 1
Editor: Bedilu Alamirie Ejigu5
PMCID: PMC10686513  PMID: 38019836

Abstract

Introduction

The severity of COVID-19 disease varies substantially between individuals, with some infections being asymptomatic while others are fatal. Several risk factors have been identified that affect the progression of SARS-CoV-2 to severe COVID-19. They include age, smoking and presence of underlying comorbidities such as respiratory illness, HIV, anemia and obesity. Given that respiratory illness is one such comorbidity and is affected by hand hygiene, it is plausible that improving access to handwashing could lower the risk of severe COVID-19 among a population. In this paper, we estimate the potential impact of improved access to handwashing on the risk of respiratory illness and its knock-on impact on the risk of developing severe COVID-19 disease across Zimbabwe.

Methods

Spatial generalized additive models were applied to cluster level data from the 2015 Demographic and Health Survey. These models were used to generate continuous (1km resolution) estimates of risk factors for severe COVID-19, including prevalence of major comorbidities (respiratory illness, HIV without viral load suppression, anemia and obesity) and prevalence of smoking, which were aggregated to district level alongside estimates of the proportion of the population under 50 from Worldpop data. The risk of severe COVID-19 was then calculated for each district using published estimates of the relationship between comorbidities, smoking and age (under 50) and severe COVID-19. Two scenarios were then simulated to see how changing access to handwashing facilities could have knock on implications for the prevalence of severe COVID-19 in the population.

Results

This modeling conducted in this study shows that (1) current risk of severe disease is heterogeneous across the country, due to differences in individual characteristics and household conditions and (2) that if the quantifiable estimates on the importance of handwashing for transmission are sound, then improvements in handwashing access could lead to reductions in the risk of severe COVID-19 of up to 16% from the estimated current levels across all districts.

Conclusions

Taken alongside the likely impact on transmission of SARS-CoV-2 itself, as well as countless other pathogens, this result adds further support for the expansion of access to handwashing across the country. It also highlights the spatial differences in risk of severe COVID-19, and thus the opportunity for better planning to focus limited resources in high-risk areas in order to potentially reduce the number of severe cases.

Introduction

Between January 2020 and March 2023, the Coronavirus pandemic (SARS-CoV-2) affected 220 countries around the world, with over 6.9 million recorded deaths and 677 million recorded cases. Given reductions in tracking and monitoring towards the end of 2022, these numbers were likely higher [1]. In Zimbabwe, there were over 5,000 reported deaths following multiple waves by September 2022 [2].

The severity of COVID-19 disease varies substantially between individuals, with some infections being asymptomatic while others are fatal. Research studies have identified a number of risk factors for severe disease which include older age, smoking and underlying comorbidities including hypertension, diabetes, cardiovascular disease and chronic respiratory disease [3–7]. As these risk factors are themselves spatially variable, the ability to identify whether and where there may be spatially heterogeneous impacts of an outbreak of SARS-CoV-2 on a population could support more effective healthcare policy and planning response scenarios.

Handwashing is widely understood to modify risk of respiratory illness as hands have been known to harbor viral respiratory pathogens [8–10]. This happens when hands come into contact with contaminated fomites (environmental surfaces) or through a person-to-person contact with a disease carrier who sheds the respiratory pathogens through their nose or mouth [11, 12]. Transmission occurs following contact between hands and nasal mucosa or mouth of the new host.

There are at least two channels through which handwashing can theoretically have an impact on reducing the number of severe COVID-19 cases in the population. The more direct pathway is by reducing transmission of the SARS-CoV-2 virus itself. A systematic review by Gozdzielewska et al [13] summarized Health authorities have established that the main transmission routes for SARS-CoV-2 are via either respiratory droplets, inhaled directly by a susceptible individual or through bodily contact [14, 15], or—while not common—via an infected surface or fomite (such as door handles or other frequently touched surfaces) [16–21]. For this reason, handwashing will likely have an impact on transmission of SARS-CoV-2 virus. Handwashing has been encouraged during the pandemic to reduce the likelihood of spreading the infection from one individual to another [17]. There have been more recent efforts to quantify [22] and determine the extent to which both hand-washing facility access [23] and handwashing or hand hygiene behavior [24–27] could impact the transmission of SARS-CoV-2. However, epidemiological modeling that sought to incorporate handwashing scenarios in predicting disease outcomes in the population at the time had to make assumptions to quantify the impact of handwashing on transmission reduction [28].

The second, more indirect pathway for handwashing in reducing prevalence of severe COVID-19 is via its impact on reducing other respiratory infections. Reducing transmission and incidence of other respiratory illnesses, would reduce prevalence of a risk factor for developing severe COVID-19 [4, 5, 7, 29, 30]. A large body of empirical studies in household and community settings have demonstrated the effectiveness of hand washing in reducing other respiratory illnesses around the world, be that through campaigns or through the presence of the facility itself. Washing hands with soap (both plain and antibacterial soap) is a proven mechanism to eliminate bacteria and respiratory viruses [31–33]. A systematic review of eight studies from a pool of 410 articles found that hand washing lowered the risk of respiratory infection, with risk reductions ranging from 6% to 44%, but noted that a greater number of rigorous studies are urgently needed [34]. Another meta-analysis suggested that regular hand hygiene provided a significant protective effect (OR = 0.62;95% CI 0.52–0.73; I2 = 0%) against 2009 pandemic influenza infection [35]. A randomized controlled trial among squatter settlements in Karachi, Pakistan, found that children younger than 5 years old living in households that were assigned to antibacterial soap had roughly a 50 percent lower incidence of pneumonia than controls [36]. Similarly, another randomized control trial across 60 elementary schools in Egypt found that a hand hygiene intervention campaign significantly reduced the incidence of laboratory-confirmed influenza by 50 percent and subsequently absenteeism among the students caused by the illnesses [37]. In Bangladesh, a study over 60,000 low-income households, found that across the sample, respiratory illness was lower among people who had soap and water present in the hand washing station than among those who did not [38]. A two-stage cluster RCT with 60 villages in Kenya also showed that children in schools where hand washing and drinking water stations were made available were consistently less likely to have an acute respiratory infection over the following 2–10 months than in schools without (2% versus 3%, Estimated Difference in Medians -2%, 90% CI-3% to -1% in rounds 1–17) [39].

Taken together, it is therefore plausible that handwashing could impact the number of hospitalizations and deaths from COVID via two pathways: 1) by reducing transmission and incidence of COVID-19 and 2) by reducing the incidence of underlying respiratory illness in a population, thereby reducing susceptibility to severe COVID-19. If a host who becomes infected with SARS-CoV-2 already has a respiratory infection the chances of that developing to severe COVID-19 disease are increased. What we focus on in the analysis presented in this paper is therefore the second, more indirect pathway described above, to impact on prevalence of severe COVID-19 cases.

This study contributes to the literature in three main ways. Firstly, it contributes to the growing body of spatially disaggregated approaches to COVID-19 but focusing on clinical risk data. Spatially disaggregated models have made use of mobility data to examine transmission dynamics [40, 41] and examined the impact of government policies [42], through lockdowns, or compared population characteristics in their response to government measures [43, 44]. However, to the best of our knowledge, this study is one of the few, particularly in the sub-Saharan African context, that have used available spatially disaggregated data on clinical risk factors to map underlying risk of severe COVID-19 in a population. Understanding spatial variation in risk using spatial modeling has proved useful for a number of diseases including malaria [45], schistosomiasis [46], and HIV [47]. In turn, clinical risk for severe COVID-19 is likely to differ across a country, so using a spatial approach has potential to be strategically useful for targeting a health policy response. Its application to severe COVID-19 risk factors is therefore applied here.

Secondly, though it is widely accepted that hand hygiene is important for reducing the spread of respiratory illnesses, and that it is important for reducing transmission of SARS-CoV-2, there have been limited efforts to map out the pathways for how handwashing can impact upon a reduction in severe COVID-19 cases. This is despite the use of hand hygiene scenarios that reduce transmission being incorporated into epidemiological models [28]. In this study we seek to build on existing literature that sought to quantify the impact of handwashing on reducing the transmission of respiratory pathogens and examine how that could have knock-on implications for the extent of severe COVID-19 prevalence.

Thirdly, this paper relies on available data to map underlying risk factors of severe COVID-19 disease and potential impact of handwashing interventions in a way that can be used for guiding policy and planning interventions. This approach is particularly useful in data scarce environments, common to developing countries.

Data and methods

Study area

In this paper we focus on Zimbabwe as a case study for the methodology being presented. Though there is an emerging collection of COVID-19 related studies within the African continent [48], the majority of studies thus far have been concentrated in Asia, North America, and Europe, while Africa focused studies are in the minority [49]. With lower rates of vaccination on average than in other parts of the world, vulnerability to severe disease remains an important concern in countries like Zimbabwe. Spatial analysis methods of this nature can be taken as a useful model for similar contexts where vaccine prioritization may be important in public health planning. It is also a data scarce environment when compared to some of the countries studied more intensively during the pandemic, and thus can provide a useful example of how similar contexts can be studied under such circumstances.

Data

The main data sets used in this analysis are: the Demographic and Health Survey (DHS) from 2015 in Zimbabwe; population density, night-time light intensity for 2015 and distance to nearest Open Street Map (OSM) road obtained via WorldPop (www.worldpop.org); and poverty Small Area Estimations (SMEs) from the World Bank at ward level [50]. The datasets used are fully outlined in Table 1.

Table 1. Data sources used to generate the covariates in the analysis.

Data Description Data Type, Resolution, Dates, Obs, sampling technique Source and Availability
Cluster locations and associated household characteristics De-identified GPS coordinates of household respondents, handwashing facilities in the home, respiratory illness prevalence, anemia, overweight prevalence, and HIV prevalence DHS 2016 https://dhsprogram.com/data/available-datasets.cfm
Pre-existing geospatial grids
Population density data Raster Facebook HDX Humanitarian Data Exchange https://data.humdata.org/dataset/worldpop-population-density-for-zimbabwe
Night-time light brightness and Digital Elevation Model Global dataset Resolution NASA (2015) ‘ASTER Level 1 Precision Terrain Corrected Registered At-Sensor Radiance Version 3’. Sioux Falls, South Dakota: NASA EOSDIS Land Processes DAAC, USGS Earth Resources Observation and Science (EROS) Center.
https://www.earthdata.nasa.gov/learn/backgrounders/nighttime-lights
https://solarsystem.nasa.gov/resources/585/asters-global-digital-elevation-model/
Distance to the nearest Open Street Map Road Raster Open StreetMap https://www.openstreetmap.org/#map=5/51.330/10.453
Poverty Small Area Estimates Polygon shapefile World Bank Poverty Global Practice https://microdata.worldbank.org/index.php/home

The 2015 DHS was used to inform the creation of a hand-washing risk index drawing from data on access to hand-washing facilities with soap and water at the household level. Respiratory illness data was taken from the same DHS survey but only available for children under five years of age. Though further data was due to be collected in 2020, this has yet to be released due to delays during the pandemic. Studies have indicated that children can often be the source of respiratory illness transmission to adults within the same household [51, 52], and thus we have used this indicator as a proxy for respiratory illness prevalence in adults at the household level. Anemia, overweight prevalence, and HIV prevalence were also taken from this source.

There are 400 clusters in the DHS distributed across the ten provinces (60 districts) of the country. Though the data is originally collected to be representative at the province level, the application of spatial modeling to such data allow for higher resolution predictions of outcomes [53, 54] such as malaria prevalence or vaccine coverage e.g., [55, 56]. Though DHS clusters are intentionally displaced by 0-2km in urban areas and 0–5 km in rural clusters, with a further, randomly selected 1% (every 100th) of rural clusters displaced by up to 10km [57]. The application of interpolation techniques specifically to DHS data is described in the referenced publication [54]. In addition, several other studies have also implemented the same interpolation techniques using DHS data [56, 58–60]. Spatial modeling approaches leveraged are described in more detail in the methods section.

The odds ratios for risk of severe disease from different clinical risk factors were taken from a meta-analysis and systematic review study of incidence and clinical characteristics and prognostic factors of patients with COVID-19 across 53,000 patients [61] and the age specific probabilities of hospitalization are taken from Estimates of the severity of coronavirus disease 2019: a model-based analysis the estimates of which can be found in S1 Table [62]. All of the source code used to generate the datasets are available at https://github.com/dime-worldbank/Disease-Modelling-SSA/tree/main/archive/risk_mapping/ZIM/R.

Methods

The methodology outlined here includes three parts. First, we calculate the prevalence of risk factors and comorbidities for severe COVID-19 at the district level, drawing on the interpolated data. Comorbidities include prevalence of respiratory illness modeled as a function of handwashing risk, anemia and obesity. Additional risk factors included prevalence of smoking and fraction of the population under the age of 50. To generate district level estimates, we applied spatial Generalized Additive Models to georeferenced cluster level DHS data to generate continuous (1km grid cells) estimates of prevalence of risk factors which are then aggregated to district level. Secondly, we use these district level prevalence estimates of risk factors to calculate the probability of developing severe COVID-19 disease using published estimates of effect sizes for these risk factors. Thirdly, we modify the level of handwashing risk according to different counterfactual scenarios in order to see the impact it has on reducing prevalence of respiratory illness and severe COVID-19 risk across the country. (All of the following analysis were conducted in R).

Predicting prevalence of risk factors and comorbidities

Handwashing risk. Using the three variables related to handwashing in the DHS data, we assign each household a hand washing ‘risk’ score. For households with a hand washing facility with water and soap, this was considered equivalent to a hand washing risk of 0. With water but no soap, there was a risk of 0.5, while with no water or no facility (even if soap was present) the risk was set to 1. The mean household level observation was then calculated for each cluster.

Cluster level georeferenced handwashing risk scores were used to predict handwashing risk across the whole country and generate a continuous map using a beta Generalized Additive Model (GAM) with a logit link function. Population density, night-time light intensity for 2015 and distance to nearest Open Street Map (OSM) road obtained via WorldPop (www.worldpop.org) were all resampled to 1km resolution and included as covariates with thin-plate splines used to model non-linear effects. These covariates were chosen due to their plausible association with poverty and access to handwashing facilities. While other covariates could be used, here the goal of the spatial modeling was to produce predictions of handwashing risk as opposed to examining factors associated with handwashing risk in detail. We also included a bivariate smooth on latitude and longitude to account for spatial autocorrelation and additional penalty term in the model to allow covariates that were not related to the outcome to essentially be removed from the model [63]. This model was used to predict handwashing risk at 1km resolution. District level handwashing risk was then estimated by calculating the population weighted mean for all cells within a district.

Respiratory illness. To generate continuous maps of respiratory illness, we calculated the prevalence of respiratory illness symptoms at any time in the two weeks preceding the survey at each DHS cluster, available for individuals aged under 5 years of age [64]. The prevalence of respiratory illness symptoms was then modeled using a binomial GAM with handwashing risk, distance to road, population density and poverty as covariates in addition to a spatial bivariate smooth. The ward level poverty estimates were rasterized to be on the same 1km resolution grid as all other covariates and included as an additional covariate. This model was then used to predict prevalence of respiratory illness at 1km resolution. District level prevalence of respiratory illness was then estimated by calculating the population weighted mean for all cells within a district.

Comorbidities and factors for the probability of severe COVID-19. In addition to respiratory illness, we generated estimates of the prevalence of several additional comorbidities and probability factors for severe COVID-19 at the district level. Individual probability factors that are included at this stage are based on existing literature and presently are HIV prevalence (without Viral Load Suppression), anemia prevalence, and obesity prevalence, in addition to respiratory illness. For each of these, prevalence was calculated at the cluster level and the same GAM model was fit to each outcome to generate predicted values at the 1km cell level. Once these gridded surfaces are created at a 1km resolution, estimates are reached at the district level by weighting, using a raster file of population count at the pixel level.

We then calculate the probability of having any of these comorbidities, defined as 1 minus the probability of having none of these comorbidities:

C=1−(1−(R.H.A.O))

where C = proportion with a comorbidity, R = proportion with respiratory illness, H = proportion with HIV (without viral load suppression), A = proportion with anaemia and O = proportion with obesity.

We apply the same geospatial methods to calculate the proportion of the population that is a smoker based on smoking prevalence within DHS clusters. We additionally calculate the proportion of the population that is over age 50 from WorldPop data.

Predicting probability of severe COVID-19

To calculate the probability of severe COVID-19, we apply the odds ratios estimated in Ma et al to the proportion with the corresponding probability factor/comorbidity at the district level.

logit(SC)=log(2.6).C+log(1.7).S+log(2.6).p50+intercept

where SC = probability of severe COVID-19, C = proportion with a comorbidity, S = proportion that smoke, p50 = proportion over 50.

In order to apply this equation, we need the intercept value specific to Zimbabwe. This was set so that the mean district level probability of severe COVID was equal to that expected on the basis of the age-breakdown of the population. To estimate this expected probability of severe COVID, we applied the Imperial College London (ICL) clinical study age-specific estimates of probability of severe disease to the age breakdown data from the Zimbabwe census from 2012. This generated a mean probability of severe disease across the population in Zimbabwe of 2.9%. After testing a range of different intercepts, an intercept of -4.2 was chosen as this produced a mean district level probability of severe disease of 2.9%.

Generating counterfactual scenarios

We produce two counterfactual scenarios for probability of severe COVID-19. These are based on predictions of prevalence of respiratory illness under different levels of handwashing risk, which affect the probability of having a comorbidity and in turn the final probability score. The first scenario uses takes the existing heterogenous values of handwashing risk throughout the country and adjusts them each to 0.25 throughout the country, equivalent to the lowest level of handwashing risk (i.e., the highest level of handwashing access) currently observed at the district level. This is a realistic scenario where it is assumed that all the districts can improve their handwashing access levels at least to the level of the best performing district. The second scenario, which shows an ideal case, uses a handwashing risk of 0, equivalent to assuming that every household has access to a hand washing facility, soap and water.

Ethics statement

This study was approved by the Medical Research Council of Zimbabwe. The approval number is MRCZ/E/302 and it was assessed as exempt. All data obtained and herein reported were anonymized prior to analysis.

Results

Handwashing risk estimates

Fig 1 shows the cluster level handwashing risk, and the district level estimates. There is considerable variation across Zimbabwe, with the lowest cluster level handwashing risk of 0.036 and highest of 0.923. At the district level, hand washing risk varied from 0.25 in Bulawayo to 0.69 in Mberengwa.

Fig 1.

Fig 1

DHS Cluster level handwashing risk across Zimbabwe in 2015 (left) and estimated district level handwashing risk (right). Basemap attribution: OpenStreetMap contributors https://www.openstreetmap.org/.

Respiratory illness probability estimates

Fig 2 shows the relationships between respiratory illness and each of the covariates explored, including the spatial effect. As expected, handwashing risk showed a general positive relationship with respiratory illness as did population density. There appeared to be a negative, but non-linear, relationship with distance to road. Poverty did not show an association with respiratory illness. In addition to the covariate effects, there appeared to be residual spatial variation in respiratory illness across the country not explained by those covariates included in the model.

Fig 2. The estimated associations between the risk factors explored and prevalence of respiratory illness in Zimbabwe, including the spatial effect (lng, lat).

Fig 2

Effect is on the log odds scale.

Predicted prevalence of respiratory illness varied across the country, with Makonde, Gokwe North and Kariba districts all having a predicted prevalence of > 0.54 and Insiza, Beitbridge and Matobo having a prevalence of < 0.26 (Fig 3).

Fig 3. Predicted prevalence of respiratory illness at the district level in Zimbabwe.

Fig 3

Basemap attribution: OpenStreetMap contributors https://www.openstreetmap.org/.

Estimates of probability of severe COVID-19

Estimates of the probability of severe disease among symptomatic cases are displayed in Fig 5. Under current conditions, probability of severe disease among symptomatic cases at the district level is predicted to vary between 0.026–0.033, with Makonde, Mutasa and Marondera districts predicted to have the highest levels of probability (Fig 4).

Fig 5. Predicted prevalence of respiratory illness at the district level in Zimbabwe—current, and under improved handwashing scenarios 1 and 2.

Fig 5

Basemap attribution: OpenStreetMap contributors https://www.openstreetmap.org/.

Fig 4. Predicted prevalence of severe COVID-19 at the district level in Zimbabwe.

Fig 4

Basemap attribution: OpenStreetMap contributors https://www.openstreetmap.org/.

Counterfactual scenarios

Under the first counterfactual scenario of reducing handwashing risk to the lowest observed levels at district level, mean prevalence of respiratory illness is predicted to drop from 0.39 to 0.32 (Fig 5B). Under the second scenario of perfect handwashing access, it drops to 0.15 (Fig 5C).

This decrease in the prevalence of respiratory illness leads to a drop in the probability of severe disease (Fig 6B and 6C). This drop is marginal if handwashing risk is set to 0.25 throughout every district (Fig 6B), with the mean district level probability of severe disease dropping from 0.029 to 0.028. This drop in risk is more substantial in a scenario of perfect access to handwashing facilities (i.e., a handwashing risk of 0), with the mean district level probability of severe disease dropping by around 16% to 0.025 (Fig 6C).

Fig 6. Predicted probability of severe COVID-19 among symptomatic cases at the district level in Zimbabwe under different hand washing risk scenarios 1 and 2.

Fig 6

Basemap attribution: OpenStreetMap contributors https://www.openstreetmap.org/.

Discussion

The severity of COVID-19 disease caused by SARS-CoV-2 is highly variable with some individuals and populations being more vulnerable to complications than others [65, 66]. Some other studies have identified spatial variation in COVID-19 severity associated with tertiary workers being at higher risk in India [67], areas with greater socio-economic inequality in Spain [68] and lower incomes and high poverty rates in the US [69]. However, few studies, particularly in the sub-Saharan African context have used available spatially disaggregated data on clinical risk factors to map underlying risk of severe COVID-19 in a population [70]. Using information on known factors for probability of severe disease and mapping it to available data on such factors from the DHS, here we estimate and map this variation using GAM [71, 72] in probability of severe disease across Zimbabwe. Results show that the probability of severe disease varies substantially with some districts having a probability of severe disease nearly 30% higher than others. Furthermore, we show that there is a relationship between handwashing and respiratory illness, a potential risk factor for severe disease, and that improving access to handwashing across the country could reduce the probability of severe disease.

From a policy perspective, this study highlights a potential added benefit of improvements to WASH facilities in addition to the already known numerous other benefits improved WASH brings. Hand washing is also an important intervention for gastro-intestinal and worm infections [34, 73–76], in addition to the relationships highlighted here for reducing transmission of respiratory infections. Taken together, this study adds another perspective on why handwashing access, particularly in developing countries, can continue to be considered as an important tool in the fight against COVID-19. Other studies have also shown it to be highly cost-effective in prevention of the spread of the virus [77], an important consideration in light of the considerable economic and societal costs of the pandemic, and associated restrictions [78, 79]. Indeed, investments in WASH are likely to lead to substantial economic returns in the absence of COVID-19. The pandemic should make this investment all the more urgent.

Limitations

While the link between handwashing and probability of severe COVID-19 is plausible, there are a number of important limitations and assumptions made as part of this study that deserve discussion. Firstly, we assumed that the prevalence of respiratory illness symptoms in children is representative of the prevalence of illness in the wider population. In reality, rates of symptoms and disease may vary between age-groups. Furthermore, many types of respiratory illness may not be severe enough to constitute being a risk factor for severe COVID-19.

Second, our results rely on the strong relationship between handwashing and respiratory illness risk based on previous studies, the causality of which has been indicated in the literature reviewed in the introduction [9, 11, 36]. However, this model does not take into account additional factors affecting respiratory illness risk e.g., indoor pollution [80, 81]. Further to this point, out of necessity, these analyses are conducted at district level using odds ratios obtained from analysis at the individual level which is not representative of the full population. While we don’t expect this to impact the main conclusions of the study, it raises the possibility of the atomistic fallacy.

Third, the comorbidities and risk factors for severe disease included in this study are not exhaustive and are limited to those for which data are available. Other factors that may pose a risk for severe disease, include TB, malaria, or hypertension (or yet to be discovered others). Further to this point, we only consider prevalence of any comorbidity as a risk factor. In reality, having more than one comorbidity is likely to increase the probability of severe disease. To incorporate this into this study would require estimates of odds ratios for each risk factor and their interactions as well as an understanding of the correlation between risk factors as these are likely to not be independent. For example, obesity has been linked to hypertension [82]. What the model seeks to do is provide a framework into which more data on risk factors can be added as and when it becomes available.

Fourth, we make the assumption that the impact of improvements in access to handwashing on prevalence of respiratory illness occurs over a timescale relevant to the pandemic. While previous research from Kenya suggests that the impact can be observed 2–9 months after intervention [39] if this timescale is longer in Zimbabwe, or if the improvements themselves take a long time to be implemented, we may not see the desired effects. One potential way to maximize impact would be to prioritize districts for improved handwashing according to their current handwashing risk. Intervention impacts could be maximized by targeting districts or communities with highest handwashing risk first. Outputs from ongoing spatially discrete agent-based modeling, informed by human movement data, could also be used to identify those districts most vulnerable to transmission.

Fifth, there are also limitations to the data that was used. The analysis was conducted during the time of emergency response so there was still limited information available on risk factors. The DHS data that was used is from 2015 due to the DHS 2020 data collection having been paused due to the pandemic. In 2023 this dataset is still not available. However, the analysis could be re-run in future with updated datasets.

Finally, this paper has only focused on underlying risk factors in the population and has not considered risk of transmission due to e.g., population mobility. The outputs of this work will likely therefore be used as part of a larger agent-based modeling exercise to identify those districts with highest probability of severe disease when transmission is also taken into account, in a separate, forthcoming paper.

In conclusion, this study shows the spatial disparity in severe COVID-19 risk across Zimbabwe. Secondly, it shows that there is a relationship between access to handwashing facilities and respiratory illness, a known risk factor for severe COVID-19. In addition to any direct effects on transmission of SARS-CoV-2, improving access to handwashing may therefore reduce the probability of severe disease among the population which could in turn reduce the number of individuals requiring hospitalization, critical care or dying from the disease.

Supporting information

S1 Table. Assumed hospitalization rates for symptomatic infections by age category.

(DOCX)

Acknowledgments

This analysis formed part of a broader collaboration of the World Bank with the Zimbabwe National Modeling Consortium. In particular the Biomedical Research and Training Institute—Institutional Review Board (BRTI-IRB) and the COVID-19 Modeling and Spatial analysis sub-group (modeling consortium); Mr. Tendayi Kureya, Executive Secretary of the Medical Research Council of Zimbabwe (MRC-Z); Dr Shungu Munyati, Director General of BRTI; Professor in Demography and Behavioral Science Simon Gregson and Dr. Mike Pickles, Research Fellow of Imperial College London (ICL). From the World Bank we would like to thank Chenjerai Sismayi from the Health, Nutrition and Population Global Practice of the World Bank as well as the Country Management Unit of the World Bank in Zimbabwe.

The findings, interpretations and conclusions expressed in this paper do not necessarily reflect the views of the World Bank, the Executive Directors of the World Bank, or the governments whom they represent. The World Bank does not guarantee the accuracy of the data included in this work.

Data Availability

The data sets used in this analysis which are publicly available are the Demographic and Health Survey from 2015 in Zimbabwe (available with registered account) (https://www.dhsprogram.com/methodology/survey/survey-display475.cfm); population density, night-time light intensity for 2016 and distance to nearest Open Street Map (OSM) road obtained from WorldPop (www.worldpop.org). Poverty Small Area Estimations (SMEs) from the World Bank at ward level can be accessed upon request to the World Bank Poverty GP or by writing to one of the World Bank authors, gjoseph@worldbank.org. All of the source code used to generate the datasets are available (https://github.com/dime-worldbank/DiseaseModelling -SSA/tree/main/risk_mapping/ZIM/R). Poverty small area estimation data are available on request to the authors of this report https://openknowledge.worldbank.org/server/api/core/bitstreams/1d1fcadc-43e3-541b-8949-fea45dd2a528/content.

Funding Statement

We would like to acknowledge the support of the Global Water Security and Sanitation Partnership (GWSP) of the World Bank and the ieConnect for Impact Program funded with UK aid from the UK government in completing this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.JHU (2021) Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html. Accessed 13 Dec 2022 [Google Scholar]
  • 2.JHU (2022) Coronavirus Resource Center- Zimbabwe. https://coronavirus.jhu.edu/region/zimbabwe. Accessed 13 Dec 2022 [Google Scholar]
  • 3.Elmore R, Schmidt L, Lam J, Howard BE, Tandon A, Norman C, et al. (2020) Risk and protective factors in the COVID-19 pandemic: a rapid evidence map. Front Public Health 8:582205 doi: 10.3389/fpubh.2020.582205 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ma Q, Shan H, Zhang H, Li G, Yang R, Chen J (2020) Potential utilities of mask‐wearing and instant hand hygiene for fighting SARS‐CoV‐2. J Med Virol 92:1567–1571 doi: 10.1002/jmv.25805 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ou M, Zhu J, Ji P, Li H, Zhong Z, Li B, et al. (2020) Risk factors of severe cases with COVID-19: a meta-analysis. Epidemiol Infect 148: doi: 10.1017/S095026882000179X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323:1239–1242 [DOI] [PubMed] [Google Scholar]
  • 7.Hu J, Wang Y (2021) The clinical characteristics and risk factors of severe COVID-19. Gerontology 67:255–266 doi: 10.1159/000513400 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.GWALTNEY JM Jr, MOSKALSKI PB, Hendley JO (1978) Hand-to-hand transmission of rhinovirus colds. Ann Intern Med 88:463–467 doi: 10.7326/0003-4819-88-4-463 [DOI] [PubMed] [Google Scholar]
  • 9.Ansari SA, Springthorpe VS, Sattar SA, Rivard S, Rahman M (1991) Potential role of hands in the spread of respiratory viral infections: studies with human parainfluenza virus 3 and rhinovirus 14. J Clin Microbiol 29:2115–2119 doi: 10.1128/jcm.29.10.2115-2119.1991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Weber TP, Stilianakis NI (2008) Inactivation of influenza A viruses in the environment and modes of transmission: a critical review. Journal of infection 57:361–373 doi: 10.1016/j.jinf.2008.08.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hendley JO, Wenzel RP, Gwaltney JM Jr (1973) Transmission of rhinovirus colds by self-inoculation. New England Journal of Medicine 288:1361–1364 doi: 10.1056/NEJM197306282882601 [DOI] [PubMed] [Google Scholar]
  • 12.Brady MT, Evans J, Cuartas J (1990) Survival and disinfection of parainfluenza viruses on environmental surfaces. Am J Infect Control 18:18–23 doi: 10.1016/0196-6553(90)90206-8 [DOI] [PubMed] [Google Scholar]
  • 13.Gozdzielewska L, Kilpatrick C, Reilly J, Stewart S, Butcher J, Kalule A, et al. (2022) The effectiveness of hand hygiene interventions for preventing community transmission or acquisition of novel coronavirus or influenza infections: a systematic review. BMC Public Health 22:1–21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Wilson N, Corbett S, Tovey E (2020) Airborne transmission of covid-19. BMJ. doi: 10.1136/bmj.m3206 [DOI] [PubMed] [Google Scholar]
  • 15.Morawska L, Milton DK (2020) It Is Time to Address Airborne Transmission of Coronavirus Disease 2019 (COVID-19). Clinical Infectious Diseases 71:2311–2313 doi: 10.1093/cid/ciaa939 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. (2020) Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England journal of medicine 382:1564–1567 doi: 10.1056/NEJMc2004973 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.World Health Organization (‎ 2020. (2020) Transmission of SARS-CoV-2: implications for infection prevention precautions: scientific brief, 09 July 2020. World Health Organization [Google Scholar]
  • 18.Goldman E (2020) Exaggerated risk of transmission of COVID-19 by fomites. Lancet Infect Dis 20:892–893 doi: 10.1016/S1473-3099(20)30561-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Mondelli MU, Colaneri M, Seminari EM, Baldanti F, Bruno R (2021) Low risk of SARS-CoV-2 transmission by fomites in real-life conditions. Lancet Infect Dis 21:e112 doi: 10.1016/S1473-3099(20)30678-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Pitol AK, Julian TR (2021) Community Transmission of SARS-CoV-2 by Surfaces: Risks and Risk Reduction Strategies. Environ Sci Technol Lett 8:263–269 doi: 10.1021/acs.estlett.0c00966 [DOI] [PubMed] [Google Scholar]
  • 21.Wiktorczyk-Kapischke N, Grudlewska-Buda K, Wałecka-Zacharska E, Kwiecińska-Piróg J, Radtke L, Gospodarek-Komkowska E, et al. (2021) SARS-CoV-2 in the environment—Non-droplet spreading routes. Science of The Total Environment 770:145260 doi: 10.1016/j.scitotenv.2021.145260 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Talic S, Shah S, Wild H, Gasevic D, Maharaj A, Ademi Z, et al. (2021) Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis. bmj 375: doi: 10.1136/bmj-2021-068302 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Zvobgo L, Do P (2020) COVID-19 and the call for ‘Safe Hands’: Challenges facing the under-resourced municipalities that lack potable water access-A case study of Chitungwiza municipality, Zimbabwe. Water Res X 9:100074 doi: 10.1016/j.wroa.2020.100074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Meda M, Gentry V, Reidy P, Garner D (2020) Unintended consequences of long-sleeved gowns in a critical care setting during the COVID-19 pandemic. Journal of Hospital Infection 106:605–609 doi: 10.1016/j.jhin.2020.07.036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Yang C (2020) Does hand hygiene reduce SARS-CoV-2 transmission? Graefe’s Archive for Clinical and Experimental Ophthalmology 258:1133–1134 doi: 10.1007/s00417-020-04652-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Hirose R, Ikegaya H, Naito Y, Watanabe N, Yoshida T, Bandou R, et al. (2021) Survival of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus on human skin: importance of hand hygiene in coronavirus disease 2019 (COVID-19). Clinical Infectious Diseases 73:e4329–e4335 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Hirose R, Bandou R, Ikegaya H, Watanabe N, Yoshida T, Daidoji T, et al. (2021) Disinfectant effectiveness against SARS-CoV-2 and influenza viruses present on human skin: model-based evaluation. Clinical Microbiology and Infection 27:1042.e1–1042.e4 doi: 10.1016/j.cmi.2021.04.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Winskill P, Whittaker C, Walker PGT, Watson O, Laydon D (2020) Report 22: Equity in response to the COVID-19 pandemic: an assessment of the direct and indirect impacts on disadvantaged and vulnerable populations in low-and lower middle-income countries. Imperial College London [Google Scholar]
  • 29.Udwadia ZF, Vora A, Tripathi AR, Malu KN, Lange C, Raju RS (2020) COVID-19-Tuberculosis interactions: When dark forces collide. indian journal of tuberculosis 67:S155–S162 doi: 10.1016/j.ijtb.2020.07.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Gao Y, Ding M, Dong X, Zhang J, Kursat Azkur A, Azkur D, et al. (2021) Risk factors for severe and critically ill COVID‐19 patients: a review. Allergy 76:428–455 doi: 10.1111/all.14657 [DOI] [PubMed] [Google Scholar]
  • 31.Luby SP, Agboatwalla M, Raza A, Sobel J, Mintz ED, Baier K, et al. (2001) Microbiologic effectiveness of hand washing with soap in an urban squatter settlement, Karachi, Pakistan. Epidemiol Infect 127:237–244 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Gibson LL, Rose JB, Haas CN, Gerba CP, Rusin PA (2002) Quantitative assessment of risk reduction from hand washing with antibacterial soaps. J Appl Microbiol 92:136S–143S [PubMed] [Google Scholar]
  • 33.Burton M, Cobb E, Donachie P, Judah G, Curtis V, Schmidt W-P (2011) The effect of handwashing with water or soap on bacterial contamination of hands. Int J Environ Res Public Health 8:97–104 doi: 10.3390/ijerph8010097 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Rabie T, Curtis V (2006) Handwashing and risk of respiratory infections: a quantitative systematic review. Tropical medicine & international health 11:258–267 doi: 10.1111/j.1365-3156.2006.01568.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Saunders-Hastings P, Crispo JAG, Sikora L, Krewski D (2017) Effectiveness of personal protective measures in reducing pandemic influenza transmission: A systematic review and meta-analysis. Epidemics 20:1–20 doi: 10.1016/j.epidem.2017.04.003 [DOI] [PubMed] [Google Scholar]
  • 36.Luby SP, Agboatwalla M, Feikin DR, Painter J, Billhimer W, Altaf A, et al. (2005) Effect of handwashing on child health: a randomised controlled trial. The Lancet 366:225–233 doi: 10.1016/S0140-6736(05)66912-7 [DOI] [PubMed] [Google Scholar]
  • 37.Talaat M, Afifi S, Dueger E, El-Ashry N, Marfin A, Kandeel A, et al. (2011) Effects of hand hygiene campaigns on incidence of laboratory-confirmed influenza and absenteeism in schoolchildren, Cairo, Egypt. Emerg Infect Dis 17:619 doi: 10.3201/eid1704.101353 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Najnin N, Leder K, Forbes A, Unicomb L, Winch PJ, Ram PK, et al. (2019) Impact of a large-scale handwashing intervention on reported respiratory illness: findings from a cluster-randomized controlled trial. Am J Trop Med Hyg 100:742 doi: 10.4269/ajtmh.18-0644 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Patel MK, Harris JR, Juliao P, Nygren B, Were V, Kola S, et al. (2012) Impact of a hygiene curriculum and the installation of simple handwashing and drinking water stations in rural Kenyan primary schools on student health and hygiene practices. Am J Trop Med Hyg 87:594 doi: 10.4269/ajtmh.2012.11-0494 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Mu X, Yeh AG-O, Zhang X (2021) The interplay of spatial spread of COVID-19 and human mobility in the urban system of China during the Chinese New Year. Environ Plan B Urban Anal City Sci 48:1955–1971 [Google Scholar]
  • 41.Zachreson C, Mitchell L, Lydeamore MJ, Rebuli N, Tomko M, Geard N (2021) Risk mapping for COVID-19 outbreaks in Australia using mobility data. J R Soc Interface 18:20200657 doi: 10.1098/rsif.2020.0657 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Guaitoli G, Pancrazi R (2021) Covid-19: Regional policies and local infection risk: Evidence from Italy with a modelling study. The Lancet Regional Health-Europe 8:100169 doi: 10.1016/j.lanepe.2021.100169 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Macharia PM, Joseph NK, Okiro EA (2020) A vulnerability index for COVID-19: Spatial analysis at the subnational level in Kenya. BMJ Glob. Health N Hav 5:e003014 doi: 10.1136/bmjgh-2020-003014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Gauvin L, Bajardi P, Pepe E, Lake B, Privitera F, Tizzoni M (2021) Socio-economic determinants of mobility responses during the first wave of COVID-19 in Italy: from provinces to neighbourhoods. J R Soc Interface 18:20210092 doi: 10.1098/rsif.2021.0092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Weiss DJ, Lucas TCD, Nguyen M, Nandi AK, Bisanzio D, Battle KE, et al. (2019) Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000–17: a spatial and temporal modelling study. The Lancet 394:322–331 doi: 10.1016/S0140-6736(19)31097-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Sturrock HJW, Pullan RL, Kihara JH, Mwandawiro C, Brooker SJ (2013) The use of bivariate spatial modeling of questionnaire and parasitology data to predict the distribution of Schistosoma haematobium in Coastal Kenya. PLoS Negl Trop Dis 7:e2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Dwyer-Lindgren L, Cork MA, Sligar A, Steuben KM, Wilson KF, Provost NR, et al. (2019) Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017. Nature 570:189–193 doi: 10.1038/s41586-019-1200-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Guleid FH, Oyando R, Kabia E, Mumbi A, Akech S, Barasa E (2021) A bibliometric analysis of COVID-19 research in Africa. BMJ Glob Health 6:e005690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Wang P, Tian D (2021) Bibliometric analysis of global scientific research on COVID-19. J Biosaf Biosecur 3:4–9 doi: 10.1016/j.jobb.2020.12.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Masaki T, Newhouse D, Silwal AR, Bedada A, Engstrom R (2020) Small area estimation of non-monetary poverty with geospatial data. [Google Scholar]
  • 51.Longini IM Jr, Koopman JS, Monto AS, Fox JP (1982) Estimating household and community transmission parameters for influenza. Am J Epidemiol 115:736–751 doi: 10.1093/oxfordjournals.aje.a113356 [DOI] [PubMed] [Google Scholar]
  • 52.MacIntyre CR, Ridda I, Seale H, Gao Z, Ratnamohan VM, Donovan L, et al. (2012) Respiratory viruses transmission from children to adults within a household. Vaccine 30:3009–3014 doi: 10.1016/j.vaccine.2011.11.047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Diggle PJ, Moraga P, Rowlingson B, Taylor BM (2013) Spatial and spatio-temporal log-Gaussian Cox processes: extending the geostatistical paradigm. Statistical Science 28:542–563 [Google Scholar]
  • 54.Burgert-Brucker CR, Group DHSSIW (2014) Spatial interpolation with demographic and health survey data: key considerations. ICF International [Google Scholar]
  • 55.Takahashi S, Metcalf CJE, Ferrari MJ, Tatem AJ, Lessler J (2017) The geography of measles vaccination in the African Great Lakes region. Nat Commun 8:1–9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Utazi CE, Wagai J, Pannell O, Cutts FT, Rhoda DA, Ferrari MJ, et al. (2020) Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: Analysis of recent household surveys. Vaccine 38:3062–3071 doi: 10.1016/j.vaccine.2020.02.070 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Burgert CR, Colston J, Roy T, Zachary B (2013) Geographic displacement procedure and georeferenced data release policy for the Demographic and Health Surveys. ICF International [Google Scholar]
  • 58.Utazi CE, Thorley J, Alegana VA, Ferrari MJ, Takahashi S, Metcalf CJE, et al. (2018) High resolution age-structured mapping of childhood vaccination coverage in low and middle income countries. Vaccine 36:1583–1591 doi: 10.1016/j.vaccine.2018.02.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Utazi CE, Thorley J, Alegana VA, Ferrari MJ, Takahashi S, Metcalf CJE, et al. (2019) Mapping vaccination coverage to explore the effects of delivery mechanisms and inform vaccination strategies. Nat Commun. doi: 10.1038/s41467-019-09611-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Yankson R, Anto EA, Chipeta MG (2019) Geostatistical analysis and mapping of malaria risk in children under 5 using point-referenced prevalence data in Ghana. Malar J. doi: 10.1186/s12936-019-2709-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Zhao X, Zhang B (2020) Li Pet al.(2020). Incidence, clinical characteristics and prognostic factor of patients with COVID-19: A systematic review and meta-analysis. medRxiv 17: [Google Scholar]
  • 62.Robert V, Okell Lucy C, Ilaria D, Peter W, Charles W, Natsuko I, et al. (2020) Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis 20:669–677 doi: 10.1016/S1473-3099(20)30243-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Marra G, Wood SN (2011) Practical variable selection for generalized additive models. Comput Stat Data Anal 55:2372–2387 [Google Scholar]
  • 64.Croft TN, Marshall AMJ, Allen CK, Arnold F, Assaf S, Balian S (2018) Guide to DHS statistics. Rockville: ICF; 645: [Google Scholar]
  • 65.Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B (2021) Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Intervirology 64:36–47 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Wang B, Li R, Lu Z, Huang Y (2020) Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY) 12:6049 doi: 10.18632/aging.103000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Saravanabavan V, Emayavaramban V, Thangamani V, Manonmani IK, Rose RSS, Balaji D, et al. (2023) Spatial variation of covid-19 morbidity status and identification of risk zone in Tamil Nadu (India) during first wave. GeoJournal 88:1341–1354 doi: 10.1007/s10708-022-10680-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Garcia-Morata M, Gonzalez-Rubio J, Segura T, Najera A (2022) Spatial analysis of COVID-19 hospitalised cases in an entire city: The risk of studying only lattice data. Science of The Total Environment 806:150521 doi: 10.1016/j.scitotenv.2021.150521 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Desmet K, Wacziarg R (2022) JUE Insight: Understanding spatial variation in COVID-19 across the United States. J Urban Econ 127:103332 doi: 10.1016/j.jue.2021.103332 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Clark A, Jit M, Warren-Gash C, et al. (2020) Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health 8:e1003–e1017 doi: 10.1016/S2214-109X(20)30264-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Hastie T, Tibshirani R (1987) Generalized additive models: Some applications. J Am Stat Assoc 82:371–386 [Google Scholar]
  • 72.Hastie TJ (2017) Generalized Additive Models. Statistical Models in S 249–307 [Google Scholar]
  • 73.Ejemot‐Nwadiaro RI, Ehiri JE, Meremikwu MM, Critchley JA (2008) Hand washing for preventing diarrhoea. Cochrane database of systematic reviews [DOI] [PubMed] [Google Scholar]
  • 74.Aiello AE, Coulborn RM, Perez V, Larson EL (2008) Effect of hand hygiene on infectious disease risk in the community setting: a meta-analysis. Am J Public Health 98:1372–1381 doi: 10.2105/AJPH.2007.124610 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Bieri FA, Gray DJ, Williams GM, Raso G, Li Y-S, Yuan L, et al. (2013) Health-education package to prevent worm infections in Chinese schoolchildren. New England Journal of Medicine 368:1603–1612 doi: 10.1056/NEJMoa1204885 [DOI] [PubMed] [Google Scholar]
  • 76.Ejemot-Nwadiaro RI, Ehiri JE, Arikpo D, Meremkwu MM, and Critchley JA (2015). Hand Washing Promotion for Preventing Diarrhea Cochrane Library Systemic Reviews Cochrane Library 9:1–95 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Bagepally BS, Haridoss M, Natarajan M, Jeyashree K, Ponnaiah M (2021) Cost-effectiveness of surgical mask, N-95 respirator, hand-hygiene and surgical mask with hand hygiene in the prevention of COVID-19: Cost effectiveness analysis from Indian context. Clin Epidemiol Glob Health 10:100702 doi: 10.1016/j.cegh.2021.100702 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Bank W (2020) The Global Economic Outlook During the COVID-19 Pandemic: A Changed World. Washington, DC: World Bank Feature Story [Google Scholar]
  • 79.Vagliasindi M (2021) Measuring the Economic Impact of COVID-19 with Real-Time Electricity Indicators. [Google Scholar]
  • 80.Smith KR, Samet JM, Romieu I, Bruce N (2000) Indoor air pollution in developing countries and acute lower respiratory infections in children. Thorax 55:518–532 doi: 10.1136/thorax.55.6.518 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Mocumbi AO, Stewart S, Patel S, Al-Delaimy WK (2019) Cardiovascular effects of indoor air pollution from solid fuel: relevance to sub-Saharan Africa. Curr Environ Health Rep 6:116–126 doi: 10.1007/s40572-019-00234-8 [DOI] [PubMed] [Google Scholar]
  • 82.Aneja A, El-Atat F, McFarlane SI, Sowers JR (2004) Hypertension and obesity. Recent Prog Horm Res 59:169–205 doi: 10.1210/rp.59.1.169 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Bedilu Alamirie Ejigu

13 Feb 2023

PONE-D-22-34494Estimating spatially disaggregated probability of severe COVID-19 and the impact of handwashing interventions: The case of ZimbabwePLOS ONE

Dear Dr. Ayling,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 30 2023 11:59PM.  If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Bedilu Alamirie Ejigu, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. Thank you for stating the following financial disclosure:

"We would like to acknowledge the support of the Global Water Security and Sanitation Partnership (GWSP) of the World Bank and the ieConnect for Impact Program  funded with UK aid from the UK government in completing this work. "

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

5. Thank you for stating the following in your Competing Interests section: 

"NO authors have competing interests"

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now

 This information should be included in your cover letter; we will change the online submission form on your behalf.

6. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

7. We note that Figures 1, 3, 4, 5 and 6 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

    1. You may seek permission from the original copyright holder of Figures 1, 3, 4, 5 and 6 to publish the content specifically under the CC BY 4.0 license. 

 We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission”

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

    2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain):  http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html  and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/   

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Dear Ms. Sophie Ayling,

Thank you for submitting your manuscript to PLOS ONE.

I have completed my evaluation of your manuscript. The reviewers recommend reconsideration of your manuscript following carful revision. I invite you to resubmit your manuscript after addressing the comments below. Please resubmit your revised manuscript by March 15, 2023.

Dealing with the estimation of spatially disaggregated probability of COVID-19 infection is an important research topic. Here the authors report the impact of improved access to handwashing on the risk of respiratory illness with spatial focus on COVID-19.

1) Abstract

- Please split this into introduction, methods, results and conclusions

2) Introduction

- This is a very good background, but the following should be addressed

i) Update the figures in the first paragraph using recent number

ii) some paragraphs lack references, such as the fourth paragraph

iii) clearly state the research problem

3) Data and Methods

- Move the “Ethics Statement” at the end of this Section, i.e. before the Result Section

- Line #131, don’t you think DHS2015 is an outdated data?

- Line #147, how the intentionally displaced DHS cluster location taken into account in the interpolation process?

- Line #154, the provided Github link not working.

- Line #158, are your sample representative to perform district level estimation?

- Line #178-180, you state about the spatial model, but unable to its clear description. How the model stated/formulated?

- Line #222, the counterfactual scenarios are similar across the country. Since there is a considerable variation in handwashing practice in Zimbabwe (see your statement line #233-244), how your assumed scenarios will be valued?

4) Results

- Fig2 (top-left), write the correct label for x- and y-axis

- Line #242. Handwashing risk highly linked with household wealth. How the authors justify the non-significant link between poverty and respiratory illness?

5) Discussion

- Lacking to compare/citation with other studies, i.e., line #301

- Why no limitations discussion here? Please add a Limitation section.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The paper discuss the severity of COVID-19 disease in different parts of Zimbabwe The disease varies substantially between individuals, with some are asymptomatic while others are fatal. Several risk factors have been identified that affect the progression of SARS-CoV-2 to severe COVID-19. To mention some age, smoking and presence of underlying comorbidities such as respiratory illness, HIV, anemia and obesity. Given that respiratory illness is one such comorbidity and is affected by hand hygiene, it suggests that improving access to handwashing could lower the risk of severe COVID-19 among a population. In the paper, the potential impact of improved access to handwashing on the risk of respiratory illness was estimated and handwashing knock-on impact on the risk of developing severe COVID-19 disease across Zimbabwe was estimated. they have used a geospatial model that allows to estimate differential clinical risk at the district level.

Results:- shows that the current risk of severe disease is heterogeneous across the country, due to differences in individual

characteristics and household conditions.

- demonstrates how household level improved access to handwashing could lead to reductions in the risk of severe COVID-19 of up to 16% from the estimated current levels across all districts. Taken alongside the likely impact on transmission of SARS-CoV-2 itself, as well as countless other pathogens,

this adds further support for the expansion of access to handwashing across the country.

It also highlights the spatial differences in risk of severe COVID-19, and concluded that it shows the opportunity for better planning to focus limited resources in high-risk areas in order to potentially reduce the number of severe cases.

my comments are:-

1)The DHS used is from 2015 while they could have used a recent one published on 2020.

2) The captions used for the figures are not well descriptive.

Reviewer #2: Manuscript Number: PONE-D-22-34494

Full Title: Estimating spatially disaggregated probability of severe COVID-19 and the impact of

handwashing interventions: The case of Zimbabwe

Short Title: The spatially disaggregated probability of severe COVID-19 and handwashing

interventions in Zimbabwe

Corresponding Author: Sophie Ayling, Ph.D. Candidate

University College London

London, UNITED KINGDOM

Reviewer Comments:

In this article, the authors addressed to estimate of the potential impact of improved access to handwashing on the risk of respiratory illness and its knock-on impact on the risk of developing severe COVID-19 disease across Zimbabwe. A geospatial model that allows the estimation of differential clinical risk at the district level was considered, in which the ideas is sounding great. Thus, the authors need to consider the following minor concerns, and address them point by point prior they move for publication:

• The abstract needs to clearly address the specific spatial method suggested to achieve the proposed objectives.

• The contribution of the work is not clear as compared with the art of the works. For instance, it’s better if the contribution of the latest work compared with the spatial-based work like (Mu X, Yeh AG-O, Zhang X (2021) and etc) is briefly explained.

• I suggest considering references that are more relevant to the current work related to spatial and cast out all which are not relevant.

• The discussion lacks references see the first paragraph of your discussion subsection.

• The datasets were taken from different sources, thus it’s better if the authors put support with the sources. The issue of the quality of the data needs to be well explained in a separate paragraph of the data source. Under the methodology the authors mentioned as they calculated the prevalence of risk factors and 158 comorbidities for severe COVID-19 at the district level, the steps how the calculation was made are not clearly addressed.

• The mathematical writing up of the entire formulas considered is not well written and clearly defining each and every term is also good. The methodology part clearly describing the models and formulas.

• Bring figures and describe them in the body of the manuscript before the references.

• The discussion part also needs to be well described as compared with the baselines. For instance, the first paragraph under the subsection should be compared with some state of the arts.

• Under the conclusion/discussion the authors mentioned as there is a relationship between access to handwashing facilities and respiratory illness, a 325 known risk factor for severe COVID-19.

• Justifying the existence of the spatial variation in the risk of severe COVID-19 needs to take into consideration.

• Better if the authors explain the spatial components taken into account in the latest work. For instance, the results, concluded as there are spatial differences in the risk of severe COVID-19. This needs to be verified through inferential spatial analysis.

Conclusion: I recommend the editor to consider the article for publication just after incorporating my major concerns.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Habte Tadesse Likassa

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Comments by HT.pdf

PLoS One. 2023 Nov 29;18(11):e0292644. doi: 10.1371/journal.pone.0292644.r002

Author response to Decision Letter 0


22 Aug 2023

Dear Reviewers and Editorial Team,

Thank you for taking the time to read and review our manuscript “Estimating spatially disaggregated probability of severe COVID-19 and the impact of handwashing interventions: The case of Zimbabwe”. We greatly appreciate the thoughtful, constructive, and detailed feedback. We have worked to address all of the comments received. Please see the document "Response to Reviewers Letter Form_160823" for our responses.

Thank you for your consideration and we will be happy to address any additional comments or feedback.

Regards,

Author Team

Attachment

Submitted filename: Response to Reviewers Letter Form_160823.docx

Decision Letter 1

Bedilu Alamirie Ejigu

26 Sep 2023

Estimating spatially disaggregated probability of severe COVID-19 and the impact of handwashing interventions: The case of Zimbabwe

PONE-D-22-34494R1

Dear Dr. Ayling,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Bedilu Alamirie Ejigu, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Bedilu Alamirie Ejigu

10 Oct 2023

PONE-D-22-34494R1

Estimating spatially disaggregated probability of severe COVID-19 and the impact of handwashing interventions: The case of Zimbabwe

Dear Dr. Ayling:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Bedilu Alamirie Ejigu

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Assumed hospitalization rates for symptomatic infections by age category.

    (DOCX)

    Attachment

    Submitted filename: Comments by HT.pdf

    Attachment

    Submitted filename: Response to Reviewers Letter Form_160823.docx

    Data Availability Statement

    The data sets used in this analysis which are publicly available are the Demographic and Health Survey from 2015 in Zimbabwe (available with registered account) (https://www.dhsprogram.com/methodology/survey/survey-display475.cfm); population density, night-time light intensity for 2016 and distance to nearest Open Street Map (OSM) road obtained from WorldPop (www.worldpop.org). Poverty Small Area Estimations (SMEs) from the World Bank at ward level can be accessed upon request to the World Bank Poverty GP or by writing to one of the World Bank authors, gjoseph@worldbank.org. All of the source code used to generate the datasets are available (https://github.com/dime-worldbank/DiseaseModelling -SSA/tree/main/risk_mapping/ZIM/R). Poverty small area estimation data are available on request to the authors of this report https://openknowledge.worldbank.org/server/api/core/bitstreams/1d1fcadc-43e3-541b-8949-fea45dd2a528/content.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES